Low Hydroxychloroquine Intake, Blood Levels Linked to ASCVD Risk in Lupus
Eating More Whole Grains Daily Linked to Cardiometabolic Benefits
Report Highlights Substance Use in Young Adults in U.S. in 2025
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD
About Half Have Meaningful Drop in Long COVID Symptoms by 36 Months
Genetic Screening Can ID Hemoglobinopathy Prevalence
Few Meet Major Clinical Response Criteria After Treatment Escalation for Lupus
Nonpharmacologic Therapy Cuts Opioid Use Disorder Risk With Low Back Pain
Low Hydroxychloroquine Intake, Blood Levels Linked to ASCVD Risk in Lupus 
Eating More Whole Grains Daily Linked to Cardiometabolic Benefits 
Report Highlights Substance Use in Young Adults in U.S. in 2025 
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD 
About Half Have Meaningful Drop in Long COVID Symptoms by 36 Months 
Genetic Screening Can ID Hemoglobinopathy Prevalence 
Few Meet Major Clinical Response Criteria After Treatment Escalation for Lupus 
Nonpharmacologic Therapy Cuts Opioid Use Disorder Risk With Low Back Pain 
